ARTICLE | Company News
Management tracks: Eisai, Nektar, ABPI
May 3, 2019 7:42 PM UTC
In the wake of recent setbacks in Alzheimer's disease, Eisai Co. Ltd. (Tokyo:4523) has charged two VPs with advancing its AD pipeline. The company hired Harald Hampel as VP, global medical affairs and named Michael Irizarry VP, clinical research.
Hampel was professor and excellence chair, scientific director at the Institute for Memory and Alzheimer's Disease, European Center of Excellence in Neurodegenerative Disease at Sorbonne University. ...